Small molecule Son of Sevenless 1 (SOS1) inhibitors: a review of the patent literature
{{output}}
Introduction: Up to 30% of all human cancers are driven by the overactivation of RAS signaling. Son of Sevenless 1 (SOS1) is a central node in RAS signaling pathways and modulation of SOS1-mediated RAS activation represents a unique opportunity for treating RA... ...
